The global market for Recombinant DNA Technology was valued at US$ 3539 million in the year 2024 and is projected to reach a revised size of US$ 6255 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Recombinant DNA Technology Market

North American market for Recombinant DNA Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant DNA Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Recombinant DNA Technology in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc., Novo Nordisk, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Technology.

The Recombinant DNA Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant DNA Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant DNA Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant DNA Technology Market Report

Report Metric	Details
Report Name	Recombinant DNA Technology Market
Accounted market size in year	US$ 3539 million
Forecasted market size in 2031	US$ 6255 million
CAGR	8.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Therapeutic Agent Vaccine Biotech Crops Specialty Chemicals
Segment by Application	Biotechnology and Pharmaceutical Companies Academic & Government Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc., Novo Nordisk, Sanofi, Merck KGaA, Profacgen, Biocon, GlaxoSmithKline, Cibus, Horizon Discovery Group, New England Biolabs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant DNA Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant DNA Technology Market growing?

Ans: The Recombinant DNA Technology Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Recombinant DNA Technology Market size in 2031?

Ans: The Recombinant DNA Technology Market size in 2031 will be US$ 6255 million.

Who are the main players in the Recombinant DNA Technology Market report?

Ans: The main players in the Recombinant DNA Technology Market are Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc., Novo Nordisk, Sanofi, Merck KGaA, Profacgen, Biocon, GlaxoSmithKline, Cibus, Horizon Discovery Group, New England Biolabs

What are the Application segmentation covered in the Recombinant DNA Technology Market report?

Ans: The Applications covered in the Recombinant DNA Technology Market report are Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, Others

What are the Type segmentation covered in the Recombinant DNA Technology Market report?

Ans: The Types covered in the Recombinant DNA Technology Market report are Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Therapeutic Agent

1.2.3 Vaccine

1.2.4 Biotech Crops

1.2.5 Specialty Chemicals

1.3 Market by Application

1.3.1 Global Recombinant DNA Technology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Academic & Government Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant DNA Technology Market Perspective (2020-2031)

2.2 Global Recombinant DNA Technology Growth Trends by Region

2.2.1 Global Recombinant DNA Technology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Recombinant DNA Technology Historic Market Size by Region (2020-2025)

2.2.3 Recombinant DNA Technology Forecasted Market Size by Region (2026-2031)

2.3 Recombinant DNA Technology Market Dynamics

2.3.1 Recombinant DNA Technology Industry Trends

2.3.2 Recombinant DNA Technology Market Drivers

2.3.3 Recombinant DNA Technology Market Challenges

2.3.4 Recombinant DNA Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant DNA Technology Players by Revenue

3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2020-2025)

3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2020-2025)

3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Recombinant DNA Technology Revenue

3.4 Global Recombinant DNA Technology Market Concentration Ratio

3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2024

3.5 Global Key Players of Recombinant DNA Technology Head office and Area Served

3.6 Global Key Players of Recombinant DNA Technology, Product and Application

3.7 Global Key Players of Recombinant DNA Technology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant DNA Technology Breakdown Data by Type

4.1 Global Recombinant DNA Technology Historic Market Size by Type (2020-2025)

4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2026-2031)

5 Recombinant DNA Technology Breakdown Data by Application

5.1 Global Recombinant DNA Technology Historic Market Size by Application (2020-2025)

5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Recombinant DNA Technology Market Size (2020-2031)

6.2 North America Recombinant DNA Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Recombinant DNA Technology Market Size by Country (2020-2025)

6.4 North America Recombinant DNA Technology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant DNA Technology Market Size (2020-2031)

7.2 Europe Recombinant DNA Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Recombinant DNA Technology Market Size by Country (2020-2025)

7.4 Europe Recombinant DNA Technology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant DNA Technology Market Size (2020-2031)

8.2 Asia-Pacific Recombinant DNA Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Recombinant DNA Technology Market Size by Region (2020-2025)

8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant DNA Technology Market Size (2020-2031)

9.2 Latin America Recombinant DNA Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Recombinant DNA Technology Market Size by Country (2020-2025)

9.4 Latin America Recombinant DNA Technology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant DNA Technology Market Size (2020-2031)

10.2 Middle East & Africa Recombinant DNA Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Recombinant DNA Technology Market Size by Country (2020-2025)

10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Monsanto Company

11.1.1 Monsanto Company Company Details

11.1.2 Monsanto Company Business Overview

11.1.3 Monsanto Company Recombinant DNA Technology Introduction

11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2020-2025)

11.1.5 Monsanto Company Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Recombinant DNA Technology Introduction

11.2.4 Roche Revenue in Recombinant DNA Technology Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Biogen

11.3.1 Biogen Company Details

11.3.2 Biogen Business Overview

11.3.3 Biogen Recombinant DNA Technology Introduction

11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2020-2025)

11.3.5 Biogen Recent Development

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Recombinant DNA Technology Introduction

11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2020-2025)

11.4.5 Amgen Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Recombinant DNA Technology Introduction

11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Details

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction

11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2020-2025)

11.6.5 Eli Lilly and Company Recent Development

11.7 GenScript

11.7.1 GenScript Company Details

11.7.2 GenScript Business Overview

11.7.3 GenScript Recombinant DNA Technology Introduction

11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2020-2025)

11.7.5 GenScript Recent Development

11.8 Pfizer Inc.

11.8.1 Pfizer Inc. Company Details

11.8.2 Pfizer Inc. Business Overview

11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction

11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2020-2025)

11.8.5 Pfizer Inc. Recent Development

11.9 Novo Nordisk

11.9.1 Novo Nordisk Company Details

11.9.2 Novo Nordisk Business Overview

11.9.3 Novo Nordisk Recombinant DNA Technology Introduction

11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2020-2025)

11.9.5 Novo Nordisk Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Recombinant DNA Technology Introduction

11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2020-2025)

11.10.5 Sanofi Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Recombinant DNA Technology Introduction

11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Profacgen

11.12.1 Profacgen Company Details

11.12.2 Profacgen Business Overview

11.12.3 Profacgen Recombinant DNA Technology Introduction

11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2020-2025)

11.12.5 Profacgen Recent Development

11.13 Biocon

11.13.1 Biocon Company Details

11.13.2 Biocon Business Overview

11.13.3 Biocon Recombinant DNA Technology Introduction

11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2020-2025)

11.13.5 Biocon Recent Development

11.14 GlaxoSmithKline

11.14.1 GlaxoSmithKline Company Details

11.14.2 GlaxoSmithKline Business Overview

11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction

11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2020-2025)

11.14.5 GlaxoSmithKline Recent Development

11.15 Cibus

11.15.1 Cibus Company Details

11.15.2 Cibus Business Overview

11.15.3 Cibus Recombinant DNA Technology Introduction

11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2020-2025)

11.15.5 Cibus Recent Development

11.16 Horizon Discovery Group

11.16.1 Horizon Discovery Group Company Details

11.16.2 Horizon Discovery Group Business Overview

11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction

11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2020-2025)

11.16.5 Horizon Discovery Group Recent Development

11.17 New England Biolabs

11.17.1 New England Biolabs Company Details

11.17.2 New England Biolabs Business Overview

11.17.3 New England Biolabs Recombinant DNA Technology Introduction

11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2020-2025)

11.17.5 New England Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

Horizon Discovery Group

New England Biolabs

List of Tables

Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Therapeutic Agent

Table 3. Key Players of Vaccine

Table 4. Key Players of Biotech Crops

Table 5. Key Players of Specialty Chemicals

Table 6. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Recombinant DNA Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Recombinant DNA Technology Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Recombinant DNA Technology Market Share by Region (2020-2025)

Table 10. Global Recombinant DNA Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Recombinant DNA Technology Market Share by Region (2026-2031)

Table 12. Recombinant DNA Technology Market Trends

Table 13. Recombinant DNA Technology Market Drivers

Table 14. Recombinant DNA Technology Market Challenges

Table 15. Recombinant DNA Technology Market Restraints

Table 16. Global Recombinant DNA Technology Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Recombinant DNA Technology Market Share by Players (2020-2025)

Table 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2024)

Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Recombinant DNA Technology, Headquarters and Area Served

Table 22. Global Key Players of Recombinant DNA Technology, Product and Application

Table 23. Global Key Players of Recombinant DNA Technology, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Recombinant DNA Technology Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2020-2025)

Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2026-2031)

Table 29. Global Recombinant DNA Technology Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Recombinant DNA Technology Revenue Market Share by Application (2020-2025)

Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Recombinant DNA Technology Revenue Market Share by Application (2026-2031)

Table 33. North America Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Recombinant DNA Technology Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Recombinant DNA Technology Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Recombinant DNA Technology Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Recombinant DNA Technology Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Recombinant DNA Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Recombinant DNA Technology Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Recombinant DNA Technology Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Recombinant DNA Technology Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Recombinant DNA Technology Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Recombinant DNA Technology Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Recombinant DNA Technology Market Size by Country (2026-2031) & (US$ Million)

Table 48. Monsanto Company Company Details

Table 49. Monsanto Company Business Overview

Table 50. Monsanto Company Recombinant DNA Technology Product

Table 51. Monsanto Company Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 52. Monsanto Company Recent Development

Table 53. Roche Company Details

Table 54. Roche Business Overview

Table 55. Roche Recombinant DNA Technology Product

Table 56. Roche Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Biogen Company Details

Table 59. Biogen Business Overview

Table 60. Biogen Recombinant DNA Technology Product

Table 61. Biogen Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 62. Biogen Recent Development

Table 63. Amgen Company Details

Table 64. Amgen Business Overview

Table 65. Amgen Recombinant DNA Technology Product

Table 66. Amgen Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 67. Amgen Recent Development

Table 68. Novartis Company Details

Table 69. Novartis Business Overview

Table 70. Novartis Recombinant DNA Technology Product

Table 71. Novartis Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 72. Novartis Recent Development

Table 73. Eli Lilly and Company Company Details

Table 74. Eli Lilly and Company Business Overview

Table 75. Eli Lilly and Company Recombinant DNA Technology Product

Table 76. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 77. Eli Lilly and Company Recent Development

Table 78. GenScript Company Details

Table 79. GenScript Business Overview

Table 80. GenScript Recombinant DNA Technology Product

Table 81. GenScript Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 82. GenScript Recent Development

Table 83. Pfizer Inc. Company Details

Table 84. Pfizer Inc. Business Overview

Table 85. Pfizer Inc. Recombinant DNA Technology Product

Table 86. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 87. Pfizer Inc. Recent Development

Table 88. Novo Nordisk Company Details

Table 89. Novo Nordisk Business Overview

Table 90. Novo Nordisk Recombinant DNA Technology Product

Table 91. Novo Nordisk Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 92. Novo Nordisk Recent Development

Table 93. Sanofi Company Details

Table 94. Sanofi Business Overview

Table 95. Sanofi Recombinant DNA Technology Product

Table 96. Sanofi Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 97. Sanofi Recent Development

Table 98. Merck KGaA Company Details

Table 99. Merck KGaA Business Overview

Table 100. Merck KGaA Recombinant DNA Technology Product

Table 101. Merck KGaA Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 102. Merck KGaA Recent Development

Table 103. Profacgen Company Details

Table 104. Profacgen Business Overview

Table 105. Profacgen Recombinant DNA Technology Product

Table 106. Profacgen Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 107. Profacgen Recent Development

Table 108. Biocon Company Details

Table 109. Biocon Business Overview

Table 110. Biocon Recombinant DNA Technology Product

Table 111. Biocon Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 112. Biocon Recent Development

Table 113. GlaxoSmithKline Company Details

Table 114. GlaxoSmithKline Business Overview

Table 115. GlaxoSmithKline Recombinant DNA Technology Product

Table 116. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 117. GlaxoSmithKline Recent Development

Table 118. Cibus Company Details

Table 119. Cibus Business Overview

Table 120. Cibus Recombinant DNA Technology Product

Table 121. Cibus Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 122. Cibus Recent Development

Table 123. Horizon Discovery Group Company Details

Table 124. Horizon Discovery Group Business Overview

Table 125. Horizon Discovery Group Recombinant DNA Technology Product

Table 126. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 127. Horizon Discovery Group Recent Development

Table 128. New England Biolabs Company Details

Table 129. New England Biolabs Business Overview

Table 130. New England Biolabs Recombinant DNA Technology Product

Table 131. New England Biolabs Revenue in Recombinant DNA Technology Business (2020-2025) & (US$ Million)

Table 132. New England Biolabs Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Recombinant DNA Technology Picture

Figure 2. Global Recombinant DNA Technology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant DNA Technology Market Share by Type: 2024 VS 2031

Figure 4. Therapeutic Agent Features

Figure 5. Vaccine Features

Figure 6. Biotech Crops Features

Figure 7. Specialty Chemicals Features

Figure 8. Global Recombinant DNA Technology Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Recombinant DNA Technology Market Share by Application: 2024 VS 2031

Figure 10. Biotechnology and Pharmaceutical Companies Case Studies

Figure 11. Academic & Government Research Institutes Case Studies

Figure 12. Others Case Studies

Figure 13. Recombinant DNA Technology Report Years Considered

Figure 14. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Recombinant DNA Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Recombinant DNA Technology Market Share by Region: 2024 VS 2031

Figure 17. Global Recombinant DNA Technology Market Share by Players in 2024

Figure 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2024

Figure 20. North America Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Recombinant DNA Technology Market Share by Country (2020-2031)

Figure 22. United States Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Recombinant DNA Technology Market Share by Country (2020-2031)

Figure 26. Germany Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Recombinant DNA Technology Market Share by Region (2020-2031)

Figure 34. China Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Recombinant DNA Technology Market Share by Country (2020-2031)

Figure 42. Mexico Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Recombinant DNA Technology Market Share by Country (2020-2031)

Figure 46. Turkey Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Recombinant DNA Technology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 51. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 52. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 54. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 55. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 56. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 57. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 58. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 59. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 60. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 61. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 63. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 64. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 65. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions